ABY -10.60%: the beauty products e-commerce business reported disappointing numbers and a softer outlook, weighing on the stock today. Revenue was a small miss to expectations despite being up +65% for the year, coming in at $199.7m. EBITDA at $5.3m was marginally below the consensus estimate as well, though EBTIDA margins were in line. FY23 expectations will have to be revised lower with the company saying sales are running at -28% on the same period last year in the first 7 weeks. While this number will normalize given it is cycling the boost from COVID lockdowns, the company doesn’t expect to see double-digit growth until the second half. Disappointingly, margins are expected to drop below the 2-4% in FY23, though they provided medium-term guidance of 8-10%for FY27, which highlights the benefit of increasing scale and growing the private label offerings.
scroll
Performance update for March, stocks that drove returns & our current positioning
Close
Friday 26th April – ASX200 -101pts, Newmont (NEM), Resmed (RMD) & Super Retail (SUL)
Close
Market Matters Research Lead Shawn Hickman with David Koch
Close
MM is neutral ABY – today’s result was weaker than we hoped
Add To Hit List
Relevant suggested news and content from the site
Video
WATCH
Performance update for March, stocks that drove returns & our current positioning
Recorded Tuesday 9th April
Podcast
LISTEN
Friday 26th April – ASX200 -101pts, Newmont (NEM), Resmed (RMD) & Super Retail (SUL)
Daily Podcast Direct from the Desk
Video
WATCH
Market Matters Research Lead Shawn Hickman with David Koch
Recorded Monday 25th March
Members only
UNLOCK MARKET MATTERS NOW
Take a free trial.
No payment details required.